| Previous close | 0.5500 |
| Open | 2.2000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 180.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.2000 - 7.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
GuruFocus.comAlpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
Simply Wall St.Results: Vertex Pharmaceuticals Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
© 2024 Yahoo. All rights reserved.